Cold Plasma Market Size, Share, and Trends 2025 to 2034

The global cold plasma market is projected to grow from USD 3.28 billion in 2025 to around USD 10.93 billion by 2034, expanding at a robust CAGR of 14.31%. Growth is driven by rising adoption in healthcare applications such as wound healing and cancer treatment, alongside increasing industrial demand and eco-friendly advantages.

Last Updated : August 2025  |  Report Code : 5187  |  Category : Chemical and Material  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Cold Plasma Market 

5.1. COVID-19 Landscape: Cold Plasma Industry Impact

5.2. COVID-19  Impact Assessment for the Industry

5.3. COVID-19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cold Plasma Market, By Pressure

8.1. Cold Plasma Market Revenue and Volume, By Pressure

8.1.1 Low-Pressure Cold Plasma

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Atmospheric Pressure Cold Plasma

8.1.2.1. Market Revenue and Volume Forecast

Chapter 9. Global Cold Plasma Market, By Application

9.1. Cold Plasma Market Revenue and Volume, By Application

9.1.1. Wound Healing

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Blood Coagulation

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Dentistry

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Cancer Treatment

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Other Medical Applications

9.1.5.1. Market Revenue and Volume Forecast

Chapter 10. Global Cold Plasma Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Volume Forecast, By Pressure

10.1.2. Market Revenue and Volume Forecast, By Application

10.1.3. U.S.

10.1.3.1. Market Revenue and Volume Forecast, By Pressure

10.1.3.2. Market Revenue and Volume Forecast, By Application

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Volume Forecast, By Pressure

10.1.4.2. Market Revenue and Volume Forecast, By Application

10.2. Europe

10.2.1. Market Revenue and Volume Forecast, By Pressure

10.2.2. Market Revenue and Volume Forecast, By Application

10.2.3. UK

10.2.3.1. Market Revenue and Volume Forecast, By Pressure

10.2.3.2. Market Revenue and Volume Forecast, By Application

10.2.4. Germany

10.2.4.1. Market Revenue and Volume Forecast, By Pressure

10.2.4.2. Market Revenue and Volume Forecast, By Application

10.2.5. France

10.2.5.1. Market Revenue and Volume Forecast, By Pressure

10.2.5.2. Market Revenue and Volume Forecast, By Application

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Volume Forecast, By Pressure

10.2.6.2. Market Revenue and Volume Forecast, By Application

10.3. APAC

10.3.1. Market Revenue and Volume Forecast, By Pressure

10.3.2. Market Revenue and Volume Forecast, By Application

10.3.3. India

10.3.3.1. Market Revenue and Volume Forecast, By Pressure

10.3.3.2. Market Revenue and Volume Forecast, By Application

10.3.4. China

10.3.4.1. Market Revenue and Volume Forecast, By Pressure

10.3.4.2. Market Revenue and Volume Forecast, By Application

10.3.5. Japan

10.3.5.1. Market Revenue and Volume Forecast, By Pressure

10.3.5.2. Market Revenue and Volume Forecast, By Application

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Volume Forecast, By Pressure

10.3.6.2. Market Revenue and Volume Forecast, By Application

10.4. MEA

10.4.1. Market Revenue and Volume Forecast, By Pressure

10.4.2. Market Revenue and Volume Forecast, By Application

10.4.3. GCC

10.4.3.1. Market Revenue and Volume Forecast, By Pressure

10.4.3.2. Market Revenue and Volume Forecast, By Application

10.4.4. North Africa

10.4.4.1. Market Revenue and Volume Forecast, By Pressure

10.4.4.2. Market Revenue and Volume Forecast, By Application

10.4.5. South Africa

10.4.5.1. Market Revenue and Volume Forecast, By Pressure

10.4.5.2. Market Revenue and Volume Forecast, By Application

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Volume Forecast, By Pressure

10.4.6.2. Market Revenue and Volume Forecast, By Application

10.5. Latin America

10.5.1. Market Revenue and Volume Forecast, By Pressure

10.5.2. Market Revenue and Volume Forecast, By Application

10.5.3. Brazil

10.5.3.1. Market Revenue and Volume Forecast, By Pressure

10.5.3.2. Market Revenue and Volume Forecast, By Application

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Volume Forecast, By Pressure

10.5.4.2. Market Revenue and Volume Forecast, By Application

Chapter 11. Company Profiles

11.1. US Medical Innovations

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Apyx Medical.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Adtec Healthcare Limited.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Bovie Medical Corporation

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Neoplas Med GmbH

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Europlasma NV

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. P2i Ltd.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. terraplasma medical GmbH

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. CINOGY System GmbH

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global cold plasma market size is expected to grow from USD 2.87 billion in 2024 to USD 10.93 billion by 2034.

The cold plasma market is anticipated to grow at a CAGR of 14.31% between 2025 and 2034.

The major players operating in the cold plasma market are US Medical Innovations, Apyx Medical., Adtec Healthcare Limited., Bovie Medical Corporation, Neoplas Med GmbH, Europlasma NV, P2i Ltd., terraplasma medical GmbH, CINOGY System GmbH, and Others.

The driving factors of the cold plasma market are the increase in the use of cold plasma in various healthcare applications.

North America region will lead the global cold plasma market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client